Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma
ConclusionsPV therapy may be a relatively safe treatment method for DLBCL patients on HD.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Dialysis | Drugs & Pharmacology | Hemodialysis | Lymphoma | Neurology | Peripheral Neuropathy | Rituxan | Study | Treanda